PBF-509   Click here for help

GtoPdb Ligand ID: 10193

Synonyms: PBF509
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: PBF-509 is an adenosine A2A receptor antagonist that is being developed by Palobiofarma [2-3]. It is being considered for clinical potential as an immuno-onclogy adjunctive agent and as a treatment for movement disorder in Parkinson's disease patients. Although the chemical structure of PBF-509 has not been formally disclosed, a comparision of published data and Palobiofarma patent documents leads us to consider Example 1 from WO2011121418A1 [1] as a likely candidate for this antagonist (binding and functional data values in the patent match data published in the peer reviewed articles that describe PBF-509). We await full disclosure to be certain of our decision.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 86.4
Molecular weight 305
XLogP 2.18
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Nc1nc(nc(c1Br)n1cccn1)n1cccn1
Isomeric SMILES Nc1nc(nc(c1Br)n1cccn1)n1cccn1
InChI InChI=1S/C10H8BrN7/c11-7-8(12)15-10(18-6-2-4-14-18)16-9(7)17-5-1-3-13-17/h1-6H,(H2,12,15,16)
InChI Key ATFXVNUWQOXRRU-UHFFFAOYSA-N
Classification Click here for help
Compound class Synthetic organic
IUPAC Name Click here for help
5-bromo-2,6-di(pyrazol-1-yl)pyrimidin-4-amine
Synonyms Click here for help
PBF509
Database Links Click here for help
BindingDB Ligand 128295
ChEMBL Ligand CHEMBL3638684
GtoPdb PubChem SID 381118903
PubChem CID 53466958
Search Google for chemical match using the InChIKey ATFXVNUWQOXRRU-UHFFFAOYSA-N
Search Google for chemicals with the same backbone ATFXVNUWQOXRRU
UniChem Compound Search for chemical match using the InChIKey ATFXVNUWQOXRRU-UHFFFAOYSA-N
UniChem Connectivity Search for chemical match using the InChIKey ATFXVNUWQOXRRU-UHFFFAOYSA-N